![]() |
Volumn 16, Issue SUPPL. 6, 2001, Pages 106-108
|
Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE DERIVATIVE;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
CEFALORIN;
CEFALOTIN;
CEFTAZIDIME;
CEPHALOSPORIN DERIVATIVE;
CHLORHEXIDINE;
CIPROFLOXACIN;
COTRIMOXAZOLE;
METICILLIN;
NYSTATIN;
PSEUDOMONIC ACID;
RIFAMPICIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ADULT;
ARTICLE;
ASEPSIS;
CATHETER INFECTION;
CHEMOPROPHYLAXIS;
CHILD;
CLINICAL FEATURE;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
DIAGNOSTIC PROCEDURE;
DISEASE PREDISPOSITION;
DISEASE TRANSMISSION;
HUMAN;
INCIDENCE;
INFECTION PREVENTION;
INFECTION RISK;
NONHUMAN;
PATHOGENESIS;
PATIENT CARE;
PATIENT SELECTION;
PERITONEAL CATHETER;
PERITONEAL FLUID;
PERITONITIS;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS INFECTION;
|
EID: 0034791471
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/16.suppl_6.106 Document Type: Article |
Times cited : (26)
|
References (13)
|